Myomo, Inc. (NYSEAMERICAN:MYO - Get Free Report) Director Thomas Kirk bought 72,000 shares of the business's stock in a transaction on Friday, March 13th. The stock was bought at an average price of $0.71 per share, with a total value of $51,120.00. Following the purchase, the director owned 553,857 shares in the company, valued at $393,238.47. This trade represents a 14.94% increase in their ownership of the stock. The purchase was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this link.
Myomo Stock Up 6.2%
MYO stock opened at $0.74 on Tuesday. The stock has a 50-day simple moving average of $0.84 and a two-hundred day simple moving average of $0.91. Myomo, Inc. has a twelve month low of $0.63 and a twelve month high of $5.62. The firm has a market capitalization of $28.49 million, a PE ratio of -2.00 and a beta of 1.17. The company has a quick ratio of 2.93, a current ratio of 3.30 and a debt-to-equity ratio of 0.98.
Analysts Set New Price Targets
Several equities analysts recently commented on the stock. Ascendiant Capital Markets reduced their price objective on shares of Myomo from $10.50 to $10.00 and set a "buy" rating for the company in a research note on Friday, November 21st. Craig Hallum reiterated a "buy" rating on shares of Myomo in a research note on Tuesday, March 10th. Four research analysts have rated the stock with a Buy rating, According to MarketBeat, the stock has a consensus rating of "Buy" and an average target price of $7.67.
Get Our Latest Stock Report on Myomo
Institutional Investors Weigh In On Myomo
A number of large investors have recently added to or reduced their stakes in the company. Cubist Systematic Strategies LLC lifted its stake in Myomo by 157.4% during the first quarter. Cubist Systematic Strategies LLC now owns 49,101 shares of the company's stock worth $236,000 after purchasing an additional 30,028 shares during the last quarter. Dynamic Technology Lab Private Ltd purchased a new position in shares of Myomo during the 1st quarter valued at about $75,000. Jane Street Group LLC lifted its position in Myomo by 84.2% in the 1st quarter. Jane Street Group LLC now owns 162,658 shares of the company's stock worth $782,000 after buying an additional 74,338 shares during the last quarter. Acadian Asset Management LLC bought a new stake in Myomo in the 1st quarter worth approximately $114,000. Finally, Geode Capital Management LLC boosted its stake in Myomo by 160.8% in the second quarter. Geode Capital Management LLC now owns 669,281 shares of the company's stock worth $1,446,000 after buying an additional 412,631 shares in the last quarter. Hedge funds and other institutional investors own 44.99% of the company's stock.
Myomo Company Profile
(
Get Free Report)
Myomo, Inc (NYSE American: MYO) is a medical robotics company specializing in developing and commercializing powered orthotic devices designed to restore mobility and function for individuals with upper-limb weakness. The company's flagship product, the MyoPro®, is an FDA-cleared, wearable robotic orthosis that leverages proprietary sensors and actuators to detect and amplify users' own muscle signals, enabling patients with conditions such as stroke, spinal cord injury, muscular dystrophy and other neuromuscular disorders to perform daily activities with greater independence.
Myomo markets the MyoPro through a network of licensed orthotic and prosthetic professionals, clinics and hospitals across North America.
See Also
This instant news alert was generated by narrative science technology and financial data from InsiderTrades.com in order to provide readers with the fastest and most accurate reporting. Please send any questions or comments about this story to [email protected].
